Cargando…

MGMT autoantibodies as a potential prediction of recurrence and treatment response biomarker for glioma patients

BACKGROUND: Cancer‐specific autoantibodies found in serum of cancer patients have been characterized as potential predictors of the high risk of recurrence and treatment response. The objective of this study is to investigate the clinical utility of serum O‐6‐methylguanine‐DNA methyltransferase (MGM...

Descripción completa

Detalles Bibliográficos
Autores principales:	Wu, Haibin, Deng, Zhitong, Wang, Hao, Li, Xuetao, Sun, Ting, Tao, Zhennan, Yao, Lin, Jin, Yanping, Wang, Xiaoying, Yang, Lan, Ma, Hongwei, Huang, Yulun, Zhou, Youxin, Du, Ziwei
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	John Wiley and Sons Inc. 2019
Materias:	Cancer Biology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6675704/ https://www.ncbi.nlm.nih.gov/pubmed/31210005 http://dx.doi.org/10.1002/cam4.2346

Ejemplares similares

Downregulation of RNF138 inhibits cellular proliferation, migration, invasion and EMT in glioma cells via suppression of the Erk signaling pathway
por: Wu, Haibin, et al.
Publicado: (2018)

Downregulation of RNF138 inhibits cellular proliferation, migration, invasion and EMT in glioma cells via suppression of the Erk signaling pathway
por: Wu, Haibin, et al.
Publicado: (2022)

Histone deacetylase inhibition up-regulates MHC class I to facilitate cytotoxic T lymphocyte-mediated tumor cell killing in glioma cells
por: Sun, Ting, et al.
Publicado: (2019)

Trps1 is associated with the multidrug resistance of lung cancer cell by regulating MGMT gene expression
por: Liu, Hongxiang, et al.
Publicado: (2018)

Dual MGMT inactivation by promoter hypermethylation and loss of the long arm of chromosome 10 in glioblastoma
por: Richard, Sophie, et al.
Publicado: (2020)

Alu hypomethylation and MGMT hypermethylation in serum as biomarkers of glioma
por: Gong, Mingjie, et al.
Publicado: (2017)

Experimental study of selective MGMT peptides mimicking TMZ drug resistance in glioma
por: Wu, Yue, et al.
Publicado: (2022)

BRD4 regulates self‐renewal ability and tumorigenicity of glioma‐initiating cells by enrichment in the Notch1 promoter region
por: Tao, Zhennan, et al.
Publicado: (2020)

Tissue-derived exosome proteomics identifies promising diagnostic biomarkers for esophageal cancer
por: Rao, Dingyu, et al.
Publicado: (2023)

Targeting transferrin receptor delivery of temozolomide for a potential glioma stem cell-mediated therapy
por: Sun, Ting, et al.
Publicado: (2017)

MicroRNA-184 inhibits cell proliferation and invasion, and specifically targets TNFAIP2 in Glioma
por: Cheng, Zhe, et al.
Publicado: (2015)

Autoantibodies against tumor‐associated antigens combined with microRNAs in detecting esophageal squamous cell carcinoma
por: Sun, Guiying, et al.
Publicado: (2019)

miR-218-5p inhibits the stem cell properties and invasive ability of the A2B5+CD133- subgroup of human glioma stem cells
por: Wu, Zhiwu, et al.
Publicado: (2022)

Significantly high expression of NUP37 leads to poor prognosis of glioma patients by promoting the proliferation of glioma cells
por: Liu, Zhendong, et al.
Publicado: (2021)

CDK5 positively regulates Notch1 signaling in pancreatic cancer cells by phosphorylation
por: Chu, Qiaoyun, et al.
Publicado: (2021)

Hyperbaric oxygen therapy sensitizes nimustine treatment for glioma in mice
por: Lu, Zhaohui, et al.
Publicado: (2016)

MCCK1 enhances the anticancer effect of temozolomide in attenuating the invasion, migration and epithelial‐mesenchymal transition of glioblastoma cells in vitro and in vivo
por: Liu, Tie, et al.
Publicado: (2019)

The immunostimulatory effects and pro‐apoptotic activity of rhCNB against Lewis lung cancer is mediated by Toll‐like receptor 4
por: Yang, Jinju, et al.
Publicado: (2019)

Screening and identification of LMNB1 and DLGAP5, two key biomarkers in gliomas
por: Zhou, Ding, et al.
Publicado: (2021)

Marinobufagenin inhibits glioma growth through sodium pump α1 subunit and ERK signaling‐mediated mitochondrial apoptotic pathway
por: Lan, Yu‐Long, et al.
Publicado: (2018)

Enhanced humoral immunity in breast cancer patients with high serum concentration of anti‐HER2 autoantibody
por: Sato, Yasufumi, et al.
Publicado: (2021)

Tissue‐based quantitative proteomics to screen and identify the potential biomarkers for early recurrence/metastasis of esophageal squamous cell carcinoma
por: Cai, Xu‐Wei, et al.
Publicado: (2018)

Identification of tRNA‐derived small noncoding RNAs as potential biomarkers for prediction of recurrence in triple‐negative breast cancer
por: Feng, Wanting, et al.
Publicado: (2018)

IBSP, a potential recurrence biomarker, promotes the progression of colorectal cancer via Fyn/β‐catenin signaling pathway
por: Chen, Yan, et al.
Publicado: (2021)

PLK1 inhibition promotes apoptosis and DNA damage in glioma stem cells by regulating the nuclear translocation of YBX1
por: Li, Xuetao, et al.
Publicado: (2023)

The nanoprodrug of polytemozolomide combines with MGMT siRNA to enhance the effect of temozolomide in glioma
por: Xu, Haoyue, et al.
Publicado: (2022)

Activation of PTGS2/NF‐κB signaling pathway enhances radiation resistance of glioma
por: Tan, Cheng, et al.
Publicado: (2019)

Targeting glioma stem cells enhances anti-tumor effect of boron neutron capture therapy
por: Sun, Ting, et al.
Publicado: (2016)

MGMT genomic rearrangements contribute to chemotherapy resistance in gliomas
por: Oldrini, Barbara, et al.
Publicado: (2020)

Piplartine attenuates the proliferation of hepatocellular carcinoma cells via regulating hsa_circ_100338 expression
por: Cheng, Xiaoli, et al.
Publicado: (2020)

14‐3‐3ζ promotes gliomas cells invasion by regulating Snail through the PI3K/AKT signaling
por: Li, Junjun, et al.
Publicado: (2019)

Uridine phosphorylase 1 is a novel immune‐related target and predicts worse survival in brain glioma
por: Wang, Jin, et al.
Publicado: (2020)

NMNAT promotes glioma growth through regulating post-translational modifications of P53 to inhibit apoptosis
por: Liu, Jiaqi, et al.
Publicado: (2021)

Circ‐UBAP2 functions as sponges of miR‐1205 and miR‐382 to promote glioma progression by modulating STC1 expression
por: Wang, Jianxin, et al.
Publicado: (2021)

Inhibition of MMP14 potentiates the therapeutic effect of temozolomide and radiation in gliomas
por: Ulasov, Ilya, et al.
Publicado: (2013)

The Zfx gene is expressed in human gliomas and is important in the proliferation and apoptosis of the human malignant glioma cell line U251
por: Zhou, Youxin, et al.
Publicado: (2011)

Study and analysis of antitumor resistance mechanism of PD1/PD‐L1 immune checkpoint blocker
por: Wang, Zhengyi, et al.
Publicado: (2020)

Treatment of recurrent malignant gliomas with fotemustine monotherapy: impact of dose and correlation with MGMT promoter methylation
por: Fabi, Alessandra, et al.
Publicado: (2009)

Do we really know who has an MGMT methylated glioma? Results of an international survey regarding use of MGMT analyses for glioma
por: Malmström, Annika, et al.
Publicado: (2020)

The Significance of MGMT Promoter Methylation Status in Diffuse Glioma
por: Jovanović, Nikola, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_8c3h6j1e6aupl0ahfc5ak4enro